Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Has Average Price Target of $493.54

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given an average recommendation of “Moderate Buy” by the thirty research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, twenty-three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $493.54.

ISRG has been the topic of several research reports. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Oppenheimer reaffirmed an “outperform” rating and issued a $500.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Wells Fargo & Company reiterated an “overweight” rating and issued a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, Mizuho cut their price target on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 21st.

Intuitive Surgical Trading Up 0.8%

NASDAQ:ISRG traded up $3.70 during mid-day trading on Friday, hitting $443.59. The company’s stock had a trading volume of 1,604,248 shares, compared to its average volume of 2,787,457. The company has a market capitalization of $153.77 billion, a price-to-earnings ratio of 53.64, a P/E/G ratio of 3.03 and a beta of 1.45. Intuitive Surgical has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock has a fifty day moving average of $417.59 and a 200-day moving average of $429.98.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the business earned $2.40 earnings per share. The company’s quarterly revenue was up 21.7% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical will post 9.37 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,150 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the transaction, the director owned 1,150 shares of the company’s stock, valued at $529,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,456 shares of company stock worth $17,769,124 in the last quarter. 0.60% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

Several large investors have recently modified their holdings of ISRG. Fairscale Capital LLC boosted its position in shares of Intuitive Surgical by 3.5% in the 3rd quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock valued at $279,000 after purchasing an additional 22 shares during the period. Beaumont Financial Advisors LLC lifted its stake in Intuitive Surgical by 3.8% during the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 23 shares in the last quarter. Hughes Financial Services LLC lifted its stake in Intuitive Surgical by 40.7% during the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 24 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co boosted its holdings in shares of Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after buying an additional 25 shares during the period. Finally, Blue Fin Capital Inc. boosted its holdings in shares of Intuitive Surgical by 0.5% in the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after buying an additional 25 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.